Ginkgo Bioworks Holdings (DNA) is a Healthcare · Biotechnology company listed on NYSE. Price $7.88 (+0.51%), Market cap $0.53B, 52-week low–high $5.48 ~ $16.14.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data
Financial statements, price targets, institutional (13F) holdings and related news for Ginkgo Bioworks Holdings are updated in real time on BlackAll Trade.
Ginkgo Bioworks Holdings trades at $7.88 (+0.51%). Real-time quotes and charts are available on BlackAll Trade.
Ginkgo Bioworks Holdings has a market cap of about $0.53B.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The co